wolverine peptides retatrutide Peptide: BPC-157 & TB-500 in The Colony TX The Wolverine Stack is helping

Participants taking tirzepatide lost an average of 15.3% of their body weight after a year, while those on semaglutide lost about 8.3%

Tirzepatide is not recommended during pregnancy or lactation, and women of reproductive potential should discontinue treatment if pregnancy is recognized

Slow titration schedules reduce side effect intensity compared to rapid dose escalation

Because of this, both drugs are expected to work in the same way for weight loss

Most commonly reported: Nausea (most common, particularly during dose escalation) Diarrhea Vomiting Constipation Abdominal discomfort These effects were generally mild to moderate in severity and tended to diminish as participants adjusted to the treatment, particularly when gradual dose escalation protocols were followed

1c and Extended Data Fig